
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so-familiar routine of online calls and deadlines has predictably returned. To cope, we are brewing a cup or three of stimulation. Our choice today is vanilla macadamia nut. Feel free to join us. Remember, no prescription is required, so need to track those pesky rebates. Meanwhile, we have assembled a few items of interest to help you get started. We hope today is productive and pleasurable. And as always, do keep in touch …
Some of the nation’s most influential doctors and public health groups are orchestrating a mad-dash effort to convince senators to confirm Robert Califf, President Biden’s pick to lead the Food and Drug Administration, STAT reports. Advocacy groups like the Campaign for Tobacco-Free Kids and Friends of Cancer Research are calling lawmakers and their staff. The American Heart Association is organizing an activist call-in campaign. The pressure campaign comes amid growing signs the nomination is in serious trouble. Five Democrats in the Senate have already expressed serious concerns and at least 10 more are still undecided about his candidacy.
What is it?
STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis.
Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.
What’s included?
- Daily reporting and analysis
- The most comprehensive industry coverage from a powerhouse team of reporters
- Subscriber-only newsletters
- Daily newsletters to brief you on the most important industry news of the day
- STAT+ Conversations
- Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
- Exclusive industry events
- Premium access to subscriber-only networking events around the country
- The best reporters in the industry
- The most trusted and well-connected newsroom in the health care industry
- And much more
- Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
DISCLAIMER
This blog is for information purposes only. The content is not intended as medical advice, diagnosis, or treatment. Should you have a medical or dermatological problem, please consult with your physician. None of the information or recommendations on this website should be interpreted as medical advice.
All product reviews, recommendations, and references are based on the author’s personal experience and impressions using the products. All views and opinions are the author’s own.
This blog post may contain affiliate links. An affiliate link means we may earn a commission if you click on a link and make a purchase, without any extra cost to you.
Please see our Disclaimer for more information.